Retrospective study of rapamycin or rapalog 0·1% cream for facial angiofibromas in tuberous sclerosis complex: evaluation of treatment effectiveness and cost
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Dermatology"
DOI: 10.1111/bjd.16397
Abstract: The use of topical rapamycin or rapalog, an mTOR inhibitor, has shown promising results in treating facial angiofibromas (FA) in children with Tuberous Sclerosis Complex (TSC). Nevertheless, several issues remain: the effectiveness, stability and tolerability… read more here.
Keywords: tuberous sclerosis; sclerosis complex; rapamycin rapalog; facial angiofibromas ... See more keywords
Is rapamycin a rapalog?
Sign Up to like & getrecommendations! Published in 2019 at "Nutrition and Healthy Aging"
DOI: 10.3233/nha-180045
Abstract: David Glass and Dudley Lamming debate the question of “Is Rapamycin a Rapalog” while the world votes. read more here.
Keywords: rapamycin rapalog; rapalog;